Beijing (AFP) | 21/01/2025 - 08:41:30 | China says hopes for cooperation with US on trade under Donald Trump
Beijing (AFP) | 21/01/2025 - 08:37:04 | China says reinstatement of Cuba on terror list shows US 'bullying'
Jakarta (AFP) | 21/01/2025 - 08:04:18 | 16 dead, 10 injured in Indonesia landslide: police
Seoul (AFP) | 21/01/2025 - 08:03:33 | S. Korea's Yoon denies ordering military to 'drag out' lawmakers in martial law bid
Washington (AFP) | 21/01/2025 - 07:54:43 | Family of American freed by Afghan Taliban express 'overwhelming gratitude'
Washington (AFP) | 21/01/2025 - 07:28:46 | Trump fires four officials in first Truth Social post since inauguration
Seoul (AFP) | 21/01/2025 - 07:26:33 | S. Korea's Yoon tells court he will respond to impeachment questions
Kabul (AFP) | 21/01/2025 - 06:12:03 | Afghan Taliban govt announces prisoner swap with US
Hong Kong (AFP) | 21/01/2025 - 03:32:40 | Property giant Country Garden up 25% as it resumes Hong Kong trading
Washington (AFP) | 21/01/2025 - 02:55:55 | Trump's pardons of US Capitol rioters 'shameful': Pelosi
AFP photographer Ben Stansall, who is 41 and became a London staff photographer in 2011, has won first prize in the "sport action" category of the British Press Photographers' Association Photographer of the Year awards. 
This is a competition for photographs taken for and used by British media.
Cabot Properties, a leading investor, developer and operator of logistics properties throughout the United States, Europe and Asia Pacific, today announced that it has expanded its European leadership team as it continues to grow its presence across the region. The firm has hired Thomas Schellhorn as Vice President to oversee asset management for Cabot’s operations in Germany and the Netherlands. In this role, he will be responsible for leasing and capital improvement programs and will report to Jed Raymond, Senior Director and Head of Asset Management for UK and Europe.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for trofinetide for the treatment of Rett syndrome in adults and pediatric patients two years of age and older. If granted marketing authorization, trofinetide will be the first and only approved therapy for Rett syndrome in the European Union (EU). Trofinetide is already approved in the United States and Canada for Rett syndrome in adults and pediatric patients two years of age and older.
The world-leading flat-panel satellite antenna company, Kymeta (www.kymetacorp.com) announced today the addition of two new members to the Board of Advisors, James Geurts and Elizabeth Kimber.
Hong Kong is embracing the richest Chinese New Year ambience among Asian cities, particular in blending in traditional and modern elements in celebrating the east-meets-west festivities, bringing travellers endless surprises. The festive in-town atmosphere this Chinese New Year is gaining extra miles as the city welcomes its newest residents, giant pandas An An and Ke Ke, who will take up residence alongside a set of soon-to-be-unveiled, local-bred giant panda twin cubs.
Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that it will present at J.P. Morgan’s 43rd Annual Healthcare Conference on Thursday, January 16, 2025.
The company’s presentation will begin at 8:30 a.m. PT/11:30 am (Eastern Time).
The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disorders with neurological involvement including GM1/GM2 gangliosidoses and Niemann Pick type C (NPC).
